91 related articles for article (PubMed ID: 12625789)
21. Loss of p21WAF1/Cip1 protein expression accompanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers.
Sinicrope FA; Roddey G; Lemoine M; Ruan S; Stephens LC; Frazier ML; Shen Y; Zhang W
Clin Cancer Res; 1998 May; 4(5):1251-61. PubMed ID: 9607584
[TBL] [Abstract][Full Text] [Related]
22. Web-based data warehouse on gene expression in human colorectal cancer.
Sagynaliev E; Steinert R; Nestler G; Lippert H; Knoch M; Reymond MA
Proteomics; 2005 Aug; 5(12):3066-78. PubMed ID: 16041676
[TBL] [Abstract][Full Text] [Related]
23. Features of colorectal cancers with high-level microsatellite instability occurring in familial and sporadic settings: parallel pathways of tumorigenesis.
Young J; Simms LA; Biden KG; Wynter C; Whitehall V; Karamatic R; George J; Goldblatt J; Walpole I; Robin SA; Borten MM; Stitz R; Searle J; McKeone D; Fraser L; Purdie DR; Podger K; Price R; Buttenshaw R; Walsh MD; Barker M; Leggett BA; Jass JR
Am J Pathol; 2001 Dec; 159(6):2107-16. PubMed ID: 11733361
[TBL] [Abstract][Full Text] [Related]
24. Identification of biomarkers to improve diagnostic sensitivity of sporadic colorectal cancer in patients with low preoperative serum carcinoembryonic antigen by clinical proteomic analysis.
Chen WT; Chang SC; Ke TW; Chiang HC; Tsai FJ; Lo WY
Clin Chim Acta; 2011 Mar; 412(7-8):636-41. PubMed ID: 21185818
[TBL] [Abstract][Full Text] [Related]
25. Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer.
Schiemann U; Günther S; Gross M; Henke G; Müller-Koch Y; König A; Muders M; Folwaczny C; Mussack T; Holinski-Feder E
Cancer Detect Prev; 2005; 29(4):356-60. PubMed ID: 16122885
[TBL] [Abstract][Full Text] [Related]
26. Analysis of apoptosis protein expression in early-stage colorectal cancer suggests opportunities for new prognostic biomarkers.
Krajewska M; Kim H; Kim C; Kang H; Welsh K; Matsuzawa S; Tsukamoto M; Thomas RG; Assa-Munt N; Piao Z; Suzuki K; Perucho M; Krajewski S; Reed JC
Clin Cancer Res; 2005 Aug; 11(15):5451-61. PubMed ID: 16061861
[TBL] [Abstract][Full Text] [Related]
27. Proteomics, genomics and transcriptomics: their emerging roles in the discovery and validation of colorectal cancer biomarkers.
Wang K; Huang C; Nice EC
Expert Rev Proteomics; 2014 Apr; 11(2):179-205. PubMed ID: 24611605
[TBL] [Abstract][Full Text] [Related]
28. Biomarkers of colorectal cancer: recent advances and future challenges.
Coghlin C; Murray GI
Proteomics Clin Appl; 2015 Feb; 9(1-2):64-71. PubMed ID: 25311658
[TBL] [Abstract][Full Text] [Related]
29. Cathepsin D protein levels in colorectal tumors: divergent expression patterns suggest complex regulation and function.
Iacobuzio-Donahue C; Shuja S; Cai J; Peng P; Willett J; Murnane MJ
Int J Oncol; 2004 Mar; 24(3):473-85. PubMed ID: 14767531
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.
Losi L; Di Gregorio C; Pedroni M; Ponti G; Roncucci L; Scarselli A; Genuardi M; Baglioni S; Marino M; Rossi G; Benatti P; Maffei S; Menigatti M; Roncari B; Ponz de Leon M
Am J Gastroenterol; 2005 Oct; 100(10):2280-7. PubMed ID: 16181381
[TBL] [Abstract][Full Text] [Related]
31. Genomics and proteomics approaches for biomarker discovery in sporadic colorectal cancer with metastasis.
González-González M; Garcia JG; Montero JA; Fernandez LM; Bengoechea O; Muñez OB; Orfao A; Sayagues JM; Fuentes M
Cancer Genomics Proteomics; 2013; 10(1):19-25. PubMed ID: 23382583
[TBL] [Abstract][Full Text] [Related]
32. Plasma clusterin as a candidate pre-diagnosis marker of colorectal cancer risk in the Florence cohort of the European Prospective Investigation into Cancer and Nutrition: a pilot study.
Bertuzzi M; Marelli C; Bagnati R; Colombi A; Fanelli R; Saieva C; Ceroti M; Bendinelli B; Caini S; Airoldi L; Palli D
BMC Cancer; 2015 Feb; 15():56. PubMed ID: 25884309
[TBL] [Abstract][Full Text] [Related]
33. The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas.
Gurzu S; Jung J; Mezei T; Pávai Z
Rom J Morphol Embryol; 2007; 48(2):95-9. PubMed ID: 17641794
[TBL] [Abstract][Full Text] [Related]
34. Colorectal cancer proteomics, molecular characterization and biomarker discovery.
Barderas R; Babel I; Casal JI
Proteomics Clin Appl; 2010 Feb; 4(2):159-78. PubMed ID: 21137041
[TBL] [Abstract][Full Text] [Related]
35. Apoptosis in colorectal carcinoma occurring in patients aged 45 years and under: relationship to prognosis, mitosis, and immunohistochemical demonstration of p53, c-myc and bcl-2 protein products.
Langlois NE; Lamb J; Eremin O; Heys SD
J Pathol; 1997 Aug; 182(4):392-7. PubMed ID: 9306959
[TBL] [Abstract][Full Text] [Related]
36. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
Ioachim E
Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
[TBL] [Abstract][Full Text] [Related]
37. An integrated proteomics and metabolomics approach for defining oncofetal biomarkers in the colorectal cancer.
Ma Y; Zhang P; Wang F; Liu W; Yang J; Qin H
Ann Surg; 2012 Apr; 255(4):720-30. PubMed ID: 22395091
[TBL] [Abstract][Full Text] [Related]
38. The usefulness of immunohistochemistry in sporadic colorectal cancer.
Vrabie CD; Ceauşu M; Petrescu A; Waller M; Dina I
Rom J Morphol Embryol; 2008; 49(4):525-35. PubMed ID: 19050802
[TBL] [Abstract][Full Text] [Related]
39. Current status and prospects of clinical proteomics studies on detection of colorectal cancer: hopes and fears.
de Noo ME; Tollenaar RA; Deelder AM; Bouwman LH
World J Gastroenterol; 2006 Nov; 12(41):6594-601. PubMed ID: 17075970
[TBL] [Abstract][Full Text] [Related]
40. The high expression of p53 in sporadic colorectal carcinoma is associated with metastasis and decreased survival.
Pancione M; Forte N; Campione S; Napolitano A; Parente D; Sabatino L; Febbraro A; Colantuoni V
Pathologica; 2010 Apr; 102(2):51-6. PubMed ID: 23596757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]